{"id":28772,"date":"2023-04-15T23:47:01","date_gmt":"2023-04-15T20:47:01","guid":{"rendered":"https:\/\/www.asperbio.com\/?page_id=28772"},"modified":"2023-09-28T00:01:29","modified_gmt":"2023-09-27T21:01:29","slug":"autoimmuunsuse-ja-lumfoproliferatsiooniga-seotud-geenide-paneel","status":"publish","type":"page","link":"https:\/\/www.asperbio.com\/et\/asper-immunogenetics-testid\/autoimmuunsuse-ja-lumfoproliferatsiooniga-seotud-geenide-paneel\/","title":{"rendered":"Autoimmuunsuse ja l\u00fcmfoproliferatsiooniga seotud geenide paneel"},"content":{"rendered":"<h2 style=\"padding-left: 5px; text-align: left;\"><span style=\"color: #a2c4e8;\">Autoimmuunsuse ja l\u00fcmfoproliferatsiooniga seotud geenide paneel<br \/>\n<\/span><\/h2>\n<div class=\"sm_post_content\" style=\"background: url('https:\/\/www.asperbio.com\/wp-content\/uploads\/Paternity-01.png') repeat-y; padding-left: 40px;\">\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Geen:<\/strong><\/td>\n<td><em>AIRE, CARMIL2, CASP8, CASP10, CD27, CD70, CTPS1, ELF4, FADD, IL10, IL10RA, IL10RB, ITCH, JAK1, MAGT1, NFAT5, PDCD1, PEPD, PRKCD, RASGRP1, RIPK1, SH2D1A, SOCS1, TET2, TGFB1, TNFRSF6 (FAS), TNFSF6 (FASLG), TNFRSF9, TPP2, XIAP<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Metoodika:<\/strong><\/td>\n<td>Kodeeriva piirkonna sekveneerimine (NGS).<br \/>\nKoopiaarvu muutuste bioinformaatiline anal\u00fc\u00fcs (CNV). CNV leidude kinnitamine teise meetodiga toimub lisaanal\u00fc\u00fcsina, vastavalt hinnakirjale.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Testi valmimisaeg:<\/strong><\/td>\n<td>6-9 n\u00e4dalat<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" style=\"width: 100%;\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 11.7155%;\" width=\"110\"><strong>N\u00f5uded proovi-materjalile:<\/strong><\/td>\n<td style=\"width: 88.1799%;\">2-4 ml t\u00e4isverd antikoagulandiga EDTA (lilla korgiga katsuti)<\/p>\n<p>1 \u00b5g DNA-d elueerituna TE, AE puhvris v\u00f5i steriilses vees, kontsentratsiooniga 100-250 ng\/\u00b5l<br \/>\nDNA saata toatemperatuuril v\u00f5i k\u00fclmutatuna. A260\/A280 suhe peaks olema 1.8-2.0. DNA peab agaroosgeelis pikkusmarkeri juuresolekul olema detekteeritav \u00fche tervikliku b\u00e4ndina.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<table class=\"table no-border no-margin\" border=\"0\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td width=\"110\"><strong>Tellimine:<\/strong><\/td>\n<td>Proovimaterjal saata koos <span style=\"color: #a2c4e8;\"><strong><a style=\"color: #a2c4e8;\" href=\"https:\/\/www.asperbio.com\/wp-content\/uploads\/Immunogeneetika_portfelli_saatekiri_20032023.docx\">saatekirjaga<\/a><\/strong><\/span> Asper Biogene laborisse<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<hr style=\"color: #a2c4e8; background-color: #a2c4e8; height: 2px; border: none; width: 100%;\" \/>\n<\/div>\n<p style=\"text-align: justify;\">","protected":false},"excerpt":{"rendered":"<p>Autoimmuunsuse ja l\u00fcmfoproliferatsiooniga seotud geenide paneel Geen: AIRE, CARMIL2, CASP8, CASP10, CD27, CD70, CTPS1, ELF4, FADD, IL10, IL10RA, IL10RB, ITCH, JAK1, MAGT1, NFAT5, PDCD1, PEPD, PRKCD, RASGRP1, RIPK1, SH2D1A, SOCS1, TET2, TGFB1, TNFRSF6 (FAS), TNFSF6 (FASLG), TNFRSF9, TPP2, XIAP Metoodika: Kodeeriva piirkonna sekveneerimine (NGS). Koopiaarvu muutuste bioinformaatiline anal\u00fc\u00fcs (CNV). CNV leidude kinnitamine teise meetodiga toimub [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":0,"parent":28734,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-28772","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/comments?post=28772"}],"version-history":[{"count":3,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28772\/revisions"}],"predecessor-version":[{"id":28818,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28772\/revisions\/28818"}],"up":[{"embeddable":true,"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/pages\/28734"}],"wp:attachment":[{"href":"https:\/\/www.asperbio.com\/et\/wp-json\/wp\/v2\/media?parent=28772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}